William H. Herman

University of Michigan — United States

Medicine · Health Sciences

107h-index62.4kcitations666works6.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Management and Research(198), Diabetes Treatment and Management(144), Diabetes, Cardiovascular Risks, and Lipoproteins(136), Diabetes Management and Education(107), Metabolism, Diabetes, and Cancer(61)

Publications628 total

Per- and polyfluoroalkyl substances and incident metabolic syndrome in midlife women: the Study of Women’s Health Across the Nation (SWAN)
SSRN Electronic Journal·2026Open Access
Cost-Effectiveness of Primary Prevention of Stroke in Type 2 Diabetes in the United States: A Microsimulation Analysis
Journal of General Internal Medicine·2025Open Access
Epidemiology of Kidney Disease in the United States
Clinical Journal of the American Society of Nephrology·2025Open Access
Hypoglycemia Beliefs, Impaired Hypoglycemia Awareness, and Severe Hypoglycemia in Insulin-Treated Type 2 Diabetes: Insights From CGM Users
Diabetes Care·2025· 1 citedOpen Access
<b>Hypoglycemia Beliefs, Impaired Hypoglycemia Awareness, and Severe Hypoglycemia in Insulin-Treated Type 2 Diabetes: Insights from CGM Users</b>
2025Open Access
<b>Hypoglycemia Beliefs, Impaired Hypoglycemia Awareness, and Severe Hypoglycemia in Insulin-Treated Type 2 Diabetes: Insights from CGM Users</b>
2025Open Access
Corrigendum to “Retention and outcomes of National Diabetes Prevention Program enrollees and non-enrollees with prediabetes: The University of Michigan experience” [J. Diabetes Complicat. (2023) 108527]
Journal of Diabetes and its Complications·2025
Real-World Interventions for Type 2 Diabetes Prevention (REALITY): A Multisite Study to Assess the Effectiveness and Cost-Effectiveness of the National Diabetes Prevention Program
AJPM Focus·2025· 1 citedOpen Access
The 2018 World Cancer Research Fund/American Institute for Cancer Research Score and Cancer Risk: results from the diabetes prevention program outcomes study
American Journal of Clinical Nutrition·2025· 1 citedOpen Access
Value-Based Pricing of Resmetirom for Metabolic Dysfunction–Associated Steatotic Liver Disease
JAMA Network Open·2025· 6 citedOpen Access
Nonglycemic and glycemic risk factors for painful neuropathic symptoms and for distal symmetrical polyneuropathy (DSPN) in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study
2025Open Access
Nonglycemic and glycemic risk factors for painful neuropathic symptoms and for distal symmetrical polyneuropathy (DSPN) in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study
2025Open Access
Nonglycemic and Glycemic Risk Factors for Painful Neuropathic Symptoms and for Distal Symmetrical Polyneuropathy (DSPN) in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study
Diabetes Care·2025· 1 citedOpen Access
1920-LB: Real-World Effectiveness of the Diabetes Prevention Program—Insights from the REALITY Research Network
Diabetes·2025
Is Screening for Heart Failure and Peripheral Artery Disease Warranted in Asymptomatic Adults With Diabetes? A Perspective on the 2025 American Diabetes Association “Standards of Care in Diabetes”
Diabetes Care·2025· 3 citedOpen Access
GLP-1 RA and dual GIP/GLP-1 RA treatment in MODY: a descriptive case series
BMJ Open Diabetes Research & Care·2025· 2 citedOpen Access
Estimated Burden of Metabolic Dysfunction–Associated Steatotic Liver Disease in US Adults, 2020 to 2050
JAMA Network Open·2025· 129 citedOpen Access
Use of Dual GIP/GLP-1 RA in HNF1A-MODY and HNF4A-MODY
Deep Blue (University of Michigan)·2025Open Access
A comment on “Metformin in the Diabetes Prevention Program 3‐year trial: The cost‐effectiveness that never was”
Diabetes Obesity and Metabolism·2024· 1 citedOpen Access
Cost-effectiveness of the National Diabetes Prevention Program: A real-world, 2-year prospective study
2024· 1 citedOpen Access
page 1 of 32Next →

Frequent Co-authors

Michael M. Engelgau(8), John M. Lachin(7), Michael Heung(7), Hal Morgenstern(7), Vahakn B. Shahinian(7), Ronald E. Aubert(6), Rajiv Saran(6), Bruce Robinson(6), Lawrence Y. Agodoa(6), Rajesh Balkrishnan(6), Jennifer L. Bragg‐Gresham(6), Paul W. Eggers(6), Richard A. Hirth(6), Steven E. Kahn(5), Steven M. Haffner(5), Kevin C. Abbott(5), Debbie S. Gipson(5), Kevin He(5), Kamyar Kalantar‐Zadeh(5), Csaba P. Kövesdy(5)